Radiosight
Radiosight develops ultra-wide imaging technology to aid in the diagnosis of skin cancer and to guide surgical decisions.
Operating in biotechnology, health care, health diagnostics based in Greater New York Area, East Coast, Northeastern US, Radiosight was founded in 2020.
Within the biotechnology, health care, health diagnostics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Greater New York Area, East Coast, Northeastern US.
The company is listed at the Grant stage of development.
Recorded headcount: c_00001_00010 employees.
Total disclosed funding stands at about $256K.
| Sector | Biotechnology, Health Care, Health Diagnostics |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $256,000 |
Website: radiosight.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account